Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Smoldering Myeloma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06745687
What this trial is testing

BCMA/CD3 BsAb in the Treatment of High-risk Smoldering Multiple Myeloma

Who this might be right for
High Risk Smoldering Multiple Myeloma
Institute of Hematology & Blood Diseases Hospital, China 20
Testing effectiveness (Phase 2)Study completedNCT01572480
What this trial is testing

Carfilzomib, Lenalidomide, and Dexamethasone for Smoldering Multiple Myeloma

Who this might be right for
Multiple Myeloma
National Cancer Institute (NCI) 55
Very early researchActive Not RecruitingNCT04370483
What this trial is testing

Leflunomide for the Treatment of High-Risk Smoldering Multiple Myeloma

Who this might be right for
Smoldering Plasma Cell Myeloma
City of Hope Medical Center 1
Not applicableLooking for participantsNCT06055894
What this trial is testing

A Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)

Who this might be right for
Multiple Myeloma, SmolderingMultiple MyelomaMonoclonal Gammopathy of Undetermined Significance
Memorial Sloan Kettering Cancer Center 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT04850846
What this trial is testing

Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma

Who this might be right for
Monoclonal Gammopathy of Undetermined SignificanceSmoldering Multiple Myeloma
Dana-Farber Cancer Institute 60
Testing effectiveness (Phase 2)Ended earlyNCT01248455
What this trial is testing

A Phase II Trial of Anti-KIR in Smoldering Multiple Myeloma

Who this might be right for
Multiple MyelomaMyelomaSmoldering Multiple Myeloma
National Cancer Institute (NCI) 9
Not applicableEnded earlyNCT01109407
What this trial is testing

Natural History Study of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Myeloma (SMM)

Who this might be right for
Smoldering MyelomaMonoclonal Gammopathy of Undetermined Significance
National Cancer Institute (NCI) 225
Not applicableUnknownNCT05047107
What this trial is testing

Biology and Genetics of Smouldering Myeloma

Who this might be right for
Smouldering MyelomaMGUSMultiple Myeloma
University College, London 500
Early research (Phase 1)Looking for participantsNCT06768489
What this trial is testing

JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide for Multiple Myeloma, Newly Diagnosed AL Amyloidosis, and High-risk Smoldering Multiple Myeloma or JNJ-79635322 in Combination With Pomalidomide for Multiple Myeloma

Who this might be right for
Multiple MyelomaSmoldering Multiple MyelomaImmunoglobulin Light-chain Amyloidosis
Janssen Research & Development, LLC 240
Testing effectiveness (Phase 2)Study completedNCT01441973
What this trial is testing

Biomarker Study of Elotuzumab in High Risk Smoldering Myeloma

Who this might be right for
Smoldering Multiple Myeloma
Bristol-Myers Squibb 41
Testing effectiveness (Phase 2)WithdrawnNCT01571726
What this trial is testing

Imaging Studies and the Development of Multiple Myeloma

Who this might be right for
Multiple MyelomaSmoldering Multiple MyelomaMonoclonal Gammopathy of Undetermined Significance
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Active Not RecruitingNCT04775550
What this trial is testing

DARA RVD For High Risk SMM

Who this might be right for
High-risk Smoldering Multiple MyelomaMultiple Myeloma
Omar Nadeem, MD 61
Testing effectiveness (Phase 2)Study completedNCT01484275
What this trial is testing

Siltuximab (Anti- IL 6 Monoclonal Antibody) in Patients With High-risk Smoldering Multiple Myeloma

Who this might be right for
High-risk Smoldering Multiple Myeloma
Janssen Research & Development, LLC 85
Testing effectiveness (Phase 2)Study completedNCT03839459
What this trial is testing

Denosumab for Smoldering Multiple Myeloma

Who this might be right for
Smoldering Multiple Myeloma
University of Rochester 20
Not applicableStudy completedNCT03951220
What this trial is testing

The Development and Pilot Testing of a New MR Imaging Protocol to Quantify Myeloma Disease Burden and Bone Loss

Who this might be right for
MyelomaMonoclonal Gammopathy of Undetermined Significance (MGUS)Smouldering Myeloma
Oxford University Hospitals NHS Trust 67
Testing effectiveness (Phase 2)Ended earlyNCT02353572
What this trial is testing

Melphalan and Bortezomib Prior to Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma

Who this might be right for
Plasma Cell MyelomaPlasmacytosisRecurrent Plasma Cell Myeloma+1 more
University of Colorado, Denver 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT04933539
What this trial is testing

Subcutaneous Daratumumab, Once Weekly Carfilzomib, and Dexamethasone (DKd) in Patients With High-Risk Smoldering Multiple Myeloma

Who this might be right for
Multiple Myeloma
National Cancer Institute (NCI) 14
Testing effectiveness (Phase 2)WithdrawnNCT00503763
What this trial is testing

Efficacy and Safety of Statin on the Course of Progressive Smoldering Multiple Myeloma

Who this might be right for
Smoldering Multiple Myeloma
Meir Medical Center
Not applicableActive Not RecruitingNCT04920084
What this trial is testing

A Plant-Based Diet in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)

Who this might be right for
Monoclonal Gammopathy of Undetermined SignificanceSmoldering Multiple Myeloma
Memorial Sloan Kettering Cancer Center 23
Not applicableStudy completedNCT00919139
What this trial is testing

S0309, Repository: Blood/Bone Marrow From Pts. With Myeloma, WM, Amyloidosis, or MGUS.

Who this might be right for
Multiple MyelomaSmoldering MyelomaWaldenstrom's Macroglobulinemia+2 more
SWOG Cancer Research Network 190
Next Page